Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor

被引:56
作者
Peh, KK [1 ]
Lim, CP
Quek, SS
Khoh, KH
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Penang 11800, Malaysia
[2] Univ Sains Malaysia, Sch Ind Technol, Penang 11800, Malaysia
关键词
multilayered perceptron; artificial neural networks; similarity factor; drug dissolution profiles;
D O I
10.1023/A:1007578321803
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Purpose. To use artificial neural networks for predicting dissolution profiles of matrix-controlled release theophylline pellet preparation, and to evaluate the network performance by comparing the predicted dissolution profiles with those obtained from physical experiments using similarity factor. Methods. The Multi-Layered Perceptron (MLP) neural network was used to predict the dissolution profiles of theophylline pellets containing different ratios of microcrystalline cellulose (MCC) and glyceryl monostearate (GMS). The concepts of leave-one-out as well as a time-point by time-point estimation basis were used to predict the rate of drug release for each matrix ratio. All the data were used for training, except for one set which was selected to compare with the predicted output. The closeness between the predicted and the reference dissolution profiles was investigated using similarity factor (f(2)). Results. The f(2) values were all above 60, indicating that the predicted dissolution profiles were closely similar to the dissolution profiles obtained from physical experiments. Conclusion. The MLP network could be used as a model for predicting the dissolution profiles of matrix-controlled release theophylline pellet preparation in product development.
引用
收藏
页码:1384 / 1388
页数:5
相关论文
共 15 条
[1]
[Anonymous], 1993, PROMISE NEURAL NETWO
[2]
NEURAL-NETWORK PREDICTED PEAK AND TROUGH GENTAMICIN CONCENTRATIONS [J].
BRIER, ME ;
ZURADA, JM ;
ARONOFF, GR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :406-412
[3]
Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274
[4]
*FDA GUID IND, 1997, EXT REL SOL OR DOS F
[5]
*FDA GUID IND, 1995, IMM REL SOL DOS FORM
[6]
*FDA GUID IND, 1997, DISS TEST IMM REL SO
[7]
*FDA GUID IND, 1997, MOD REL SOL DOS FORM
[8]
APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT [J].
HUSSAIN, AS ;
YU, XQ ;
JOHNSON, RD .
PHARMACEUTICAL RESEARCH, 1991, 8 (10) :1248-1252
[9]
FEASIBILITY OF DEVELOPING A NEURAL NETWORK FOR PREDICTION OF HUMAN PHARMACOKINETIC PARAMETERS FROM ANIMAL DATA [J].
HUSSAIN, AS ;
JOHNSON, RD ;
VACHHARAJANI, NN ;
RITSCHEL, WA .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :466-469
[10]
Manly B. F., 1986, MULTIVARIATE STAT ME